These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
856 related articles for article (PubMed ID: 25839163)
1. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163 [TBL] [Abstract][Full Text] [Related]
2. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway. Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival. Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362 [TBL] [Abstract][Full Text] [Related]
4. Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer. Kobayashi M; Sawada K; Miyamoto M; Shimizu A; Yamamoto M; Kinose Y; Nakamura K; Kawano M; Kodama M; Hashimoto K; Kimura T Biochem Biophys Res Commun; 2020 Jun; 527(1):153-161. PubMed ID: 32446360 [TBL] [Abstract][Full Text] [Related]
5. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway. Zeng B; Shi W; Tan G BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2. Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893 [TBL] [Abstract][Full Text] [Related]
7. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]
8. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway. Li SQ; Wang ZH; Mi XG; Liu L; Tan Y IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
10. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA MTO1 inhibits gastric cancer progression by elevating PAWR via sponging miR-199a-3p. Song R; Li Y; Hao W; Yang L; Chen B; Zhao Y; Sun B; Xu F Cell Cycle; 2020 Nov; 19(22):3127-3139. PubMed ID: 33089757 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180 [TBL] [Abstract][Full Text] [Related]
13. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression. Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. Cheng W; Liu T; Wan X; Gao Y; Wang H FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306 [TBL] [Abstract][Full Text] [Related]
15. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8. Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
17. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670 [TBL] [Abstract][Full Text] [Related]
18. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. Hu Y; Li D; Wu A; Qiu X; Di W; Huang L; Qiu L Cancer Lett; 2017 May; 393():60-67. PubMed ID: 28216373 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway. Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Duan Z; Choy E; Harmon D; Liu X; Susa M; Mankin H; Hornicek F Mol Cancer Ther; 2011 Aug; 10(8):1337-45. PubMed ID: 21666078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]